John Libbey Eurotext

Hépato-Gastro & Oncologie Digestive

MENU

Obesity and IBD: consequences and treatment Volume 29, issue 7, September 2022

Figures

  • Figure 1
  • Figure 2
Authors
1 Clinique mutualiste Saint-Étienne, 3 rue le Verrier, 42100 Saint-Étienne
2 CHU de Saint-Étienne, Service d’hépato-gastro-entérologie, Avenue Albert Raimond, 42270 Saint-Priest-en-Jarez
Correspondance : X. Roblin

Obesity is a major healthcare problem worldwide. Incidence of IBD is rising in parallel with overweight and obesity. As a consequence, a great number of IBD patients could be evaluated for a bariatric surgery. It appears that obesity has a negative impact on IBD, with pro inflammatory effects. Treatment pharmacokinetic is impacted. Bariatric surgery is feasible with no increase of post operative complications. A change in microbiote and an effect on fecal calprotectin is described.